David Ho’s 1990s research helped shed light on how HIV replicates. Now, his research aims to stem replication of the coronavirus. aapifrontline
The data out there are telling us it would be unwise to let up so soon. We're quite a bit behind Western Europe in terms of the epidemic curve. We're still at the crest, maybe coming down a little bit. But it's not time to let up. You're just begging for trouble.Ho: I think for some place like New York City, where I live, you really need to test, try to aim for at least 1 percent, if not several percent, of the population to get a clear view of where we actually are.
We're just ignoring other people's experiences. There are enough examples out there teaching us that by going back too soon, you actually delay the ultimate return to normality. Ho: Yeah. It was called GRID for quite a while. Some other names that are much worse. There's no place for that. Everybody who tested positive was followed very, very closely by an app and by monitors who would track these people, check in with them on a twice-a-day basis. Should they leave the house with their phone, that would be picked up, a reminder would be sent.
Obviously, we pay more emphasis on civil liberties than perhaps they do, even though Taiwan is pretty open and free. But I think the citizenry is much more compliant there than Americans here. Ho: First of all, China could've been more transparent earlier on, particularly in Wuhan. If they made a mistake about human-to-human transmission in the first few weeks of January, they could say so.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New York's famed stock exchange prepares to reopen — with masks and a waiverWhite-haired Peter Tuchman, the most photographed person on the trading floor, will not be back on Tuesday. In March, he tested positive for COVID-19.
Read more »
WHO drops hydroxychloroquine from global study of experimental COVID-19 treatmentsThe World Health Organization said that it will temporarily drop hydroxychloroquine — the malaria drug U.S. President Trump has said he is taking — from its...
Read more »
WHO drops hydroxychloroquine from global study of experimental COVID-19 treatmentsThe World Health Organization said that it will temporarily drop hydroxychloroquine — the malaria drug U.S. President Trump has said he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date.
Read more »
WHO Suspends Hydroxychloroquine Study Over Safety ConcernsThe news comes after a paper published last week showed people taking hydroxychloroquine were at higher risk of death
Read more »
Coronavirus ‘silent spreaders’ become a bigger risk as California reopensThere’s increasing concern that people infected with COVID-19 who show no signs of illness are playing a large role in the transmission of COVID-19.
Read more »
Brazil to continue using hydroxychloroquine to treat coronavirus patients, despite WHO's safety fearsThe World Health Organization suspended a trial assessing hydroxychloroquine as a COVID-19 treatment due to safety concerns.
Read more »